N-Ethylhexedrone was patented via the German pharmaceutical enterprise Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[one]Disclaimer: The effects listed under cite the Subjective Impact Index (SEI), an open up investigation literature dependant on anecdo